Camzyos
*Company:
Bristol-Myers Squibb Pharma EEIGStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
File name
IE Camzyos HCP Mass Mailer Letter 2025_Final_Signed.pdf
Reasons for updating
- Add New Doc
File name
3500-IE-2500004_Camzyos Patient Card IE_Accessible.pdf
Reasons for updating
- Add New Doc
File name
3500-IE-2500003_Camzyos Patient Guide IE_Accessible.pdf
Reasons for updating
- Add New Doc
File name
3500-IE-2500002_Camzyos HCP Checklist IE.pdf
Reasons for updating
- Add New Doc
Updated on 01 May 2026
File name
ie-spc-clean (30May2025).pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 May 2026
File name
ie-pil-clean (12Dec24).pdf
Reasons for updating
- New PIL for new product
Bristol-Myers Squibb Pharma EEIG
Address:
Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, IrelandMedical Information E-mail:
medical.information@bms.comTelephone:
+353 1 483 3625Medical Information Direct Line:
Freephone 1 800 749 749Stock Availability:
bmscustomer-service.chester@bms.com